Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis	Disease Attributes, Neuroinflammatory Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, brain disorder, central nervous system disorder, encephalitis, immune system disorder, nervous system disorder	Recruiting	Phase 2	2025-07-01		NCT04372615

Clinical trials